International Maternal Pediatrics Adolescent AIDS Clinic (IMPAACT) |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Pharmacokinetic analysis of dihydroartemisinin-piperaquine alongside the START-IPT Study |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Pediatrics |
|
|
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Optimizing ACT use for African children in the setting of HIV and malnutrition |
Francesca Aweeka, PharmD |
HIV/AIDS, Malaria, Malnutrition, Micronutrients, Food Insecurity |
|
|
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
A Genome Wide Characterization of the Erythrocytic Cell Cycle of the Human Parasite Plasmodium |
Joseph Derisi, PhD |
Malaria |
|
|
Development of Proteome-scale Peptide Bead Suspension Arrays for Immunoprofiling and Vaccine Development by Multi Channel Microfludic Flow Sorting. |
Joseph Derisi, PhD |
Malaria |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Novel Anti-Malarials by Combinatorial Pharmacogenomics |
Joseph Derisi, PhD |
Infectious Disease, Malaria, Drug and Diagnostics Development |
|
|
Development of Anti-Malarial Preclinical Candidates |
Joseph Derisi, PhD |
Malaria |
|
|
Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Using Apicoplast-Deficient Parasites to Identify Anti-Malaria Compounds That Specifically Target This Organelle |
Joseph Derisi, PhD |
Malaria |
|
|
A Functional Genomics Approach to Identification of New Anti-Malarial Drug Targets |
Joseph Derisi, PhD |
Malaria |
|
|
Program for Resistance, Immunology, Surveillance, and Modeling of Malaria in Uganda (PRISM) |
Grant Dorsey, MD |
Malaria, Epidemiology and Surveillance |
|
|
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI) |
Grant Dorsey, MD |
Malaria |
|
|
Impact of long-lasting insecticide treated bednets with and without PBO on malaria indicators in Uganda: a cluster randomised trial |
Grant Dorsey, MD |
Malaria |
|
|
Estimating the impact of indoor residual spraying of insecticide using a novel health facility-based malaria surveillance program in Uganda |
Grant Dorsey, MD |
Malaria, Epidemiology and Surveillance |
|
|
Evaluation of the community impact of START-IPT |
Grant Dorsey, MD |
Malaria |
|
|
Global Malaria Prevention and Control |
Grant Dorsey, MD |
Malaria |
|
|
Interactions Between HIV and Malaria in African Children |
Grant Dorsey, MD |
HIV/AIDS, Malaria |
|
|
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda |
Grant Dorsey, MD |
Malaria, Epidemiology and Surveillance, Global Strategic Information, Training International Scholars and Clinicians |
|
|
Supporting the Implementation of Malaria Prevention and Control Strategies and Relevant Ancillary Activities in the Republic of Uganda |
Grant Dorsey, MD |
Malaria, Implementation and Behavioral Science |
|
|
PBO Study: Impact of LLINs with and without PBO in Uganda: a cluster-randomised trial - Innovative Vector Control Consortium (IVCC) |
Grant Dorsey, MD |
Malaria |
|
|
Clinical and Molecular Studies of Drug-Resistant Malaria [II] |
Grant Dorsey, MD |
Malaria |
|
|
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI) |
Grant Dorsey, MD |
Malaria, Pediatrics |
|
|
Building a Stronger Evidence Base on Malaria Elimination |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness |
|
|
Accelerating Malaria Elimination in Southern Africa and Beyond: A Country and Global Initiative |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness |
|
|
The Global Health Group - From Analysis to Action |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Purging the Burden: Expanding Malaria Elimination in Southern Africa |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Achieving Global Malaria Eradication through Accelerated Regional Elimination |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
Accelerating progress towards Malaria Eradication: Working across Global, Regional, and National levels, and through Operational Research, to Shrink the Malaria Map |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
The Center for Policy Impact in Global Health & the Capstone Year (phase IV) of the Commission on Investing in Health |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
Grant to support UCSF Global Health Impact Fund |
Richard Feachem, DSc, PhD |
Malaria |
|
|
Evidence for Global Health Advocacy |
Richard Feachem, DSc, PhD |
Malaria, Health Economics and Effectiveness |
|
|
Mentoring Translational Researchers for Careers in Pediatric Global Health |
Margaret Feeney, MD |
Malaria, Pediatrics, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training |
|
|
Effector and regulatory T cell responses and protection from clinical malaria |
Margaret Feeney, MD |
Malaria, Drug and Diagnostics Development, Immunology |
|
|
Effector and Regulatory T Cell Responses and Protection from Clinical Malaria |
Margaret Feeney, MD |
Malaria |
|
|
Insights into Plasmodium falciparum Interactions with the Human Placenta |
Susan Fisher, PhD |
Malaria, Women's Health, Newborn and Infant Health |
|
|
PlasmoTrack: Spatiotemporal Tracking of Malaria Parasites |
Bryan Greenhouse, MD |
Malaria |
|
|
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory |
Bryan Greenhouse, MD |
Malaria, Immunology, Pediatrics |
|
|
Applying molecular epidemiology to accelerate to zero |
Bryan Greenhouse, MD |
Malaria, Epidemiology and Surveillance |
|
|
Profiling the Development of Humoral Antimalarial Immunity |
Bryan Greenhouse, MD |
Malaria |
|
|
Novel serologic assays of P. falciparum exposure for improved surveillance in control and elimination |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
P.falciparum infection dynamics and transmission to inform elimination (INDIE) |
Bryan Greenhouse, MD |
Malaria, Pharmacology and Drug Treatment |
|
|
Hologic - Analytical sensitivity comparison of a new molecular assay for Plasmodium detection with a qualitative nested PCR assay and a quantitative PCR assay 20150330 |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Biomarkers for Malaria Eradication (BIOME) |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Malaria Serology evaluation |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Translational Studies of Plasmodium Falciparum Infection Dynamics |
Bryan Greenhouse, MD |
Malaria |
|
|
Modeling malaria incidence in Uganda using sentinel site surveillance data |
Bryan Greenhouse, MD |
Malaria, Epidemiology and Surveillance |
|
|
Dried Blood Spots on Filter Paper |
Bryan Greenhouse, MD |
Malaria |
|
|
A Molecular Strategy to Determine the Origins of Malaria Cases and Map Transmission Potential in Countries Approaching Elimination |
Bryan Greenhouse, MD |
Malaria |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) |
Diane Havlir, MD |
HIV/AIDS, Malaria |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) |
Diane Havlir, MD |
HIV/AIDS, Malaria |
|
|
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa |
Diane Havlir, MD |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Clinical Studies of Interactions Between HIV and Malaria |
Diane Havlir, MD |
HIV/AIDS, Malaria |
|
|
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) |
Diane Havlir, MD |
HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health |
|
|
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates |
Diane Havlir, MD |
HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes |
|
|
Impact of Parasitemia on the Development of Cellular Immune Responses to Malaria |
|
Malaria |
|
|
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention |
|
Malaria |
|
|
Immunological Detection and Control of Experimental Uncomplicated Malaria |
|
Malaria |
|
|
Proteomic Analysis of Antigenic Switching in the Malaria Parasite |
|
Malaria, Residencies, Fellowships, and Postdoctoral Training |
|
|
Immunological Detection and Control of Experimental Uncomplicated Malaria |
|
Malaria |
|
|
Planning Grant for a large scale azithromycin trial for prevention of under-5 mortality in Niger |
Thomas Lietman, MD |
Malaria, Eye Disease and Blindness, Pediatrics |
|
|
Interferon-independent mechanisms of malaria restriction by helper T cells |
Mike McCune, MD, PhD |
HIV/AIDS, Malaria, Immunology |
|
|
Improving Malaria Diagnosis and Treatment in Nigeria: Taking a Pilot Study to Scale |
Dominic Montagu, DrPH |
Malaria, Health Systems Strengthening |
|
|
The Private Delivery of Malaria Treatment: Generating Information to Rapidly Scale-Up Program |
Dominic Montagu, DrPH |
Malaria |
|
|
Improving Malaria Treatment Practices in Myanmar's Private Sector: An Evaluation of Incentives for Driving Demand for Diagnostic Tools |
Dominic Montagu, DrPH |
Malaria, Health Economics and Effectiveness, Health Systems Strengthening |
|
|
Innovative Models for Private Malaria Care in Nigeria |
Dominic Montagu, DrPH |
Malaria |
|
|
Ensuring Proper Malaria Diagnosis and Treatment in Nigeria: Piloting Incentives for Diagnostics in the Private Sector |
Dominic Montagu, DrPH |
Malaria |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Pharmacogenomics of Antimalarial Drugs |
Sunil Parikh, MD, MPH |
Malaria, Genetics, Pharmacology and Drug Treatment |
|
|
Host Polymorphisms and Uncomplicated Malaria |
Sunil Parikh, MD, MPH |
Malaria |
|
|
Genome-wide Association Data |
Sunil Parikh, MD, MPH |
Malaria |
|
|
Discovery of Novel Antimalarial Leads Targeting Translational Repression in Plasmodium parasites |
Adam Renslo, PhD |
Malaria |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Malaria |
|
|
Chemical Methods for Ferrous Iron Targeted Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Training in Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building |
|
|
Development of Falcipain Inhibitors as Antimalarial Drugs |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Global Malaria Prevention and Control |
Philip J. Rosenthal, MD |
Malaria |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Etiology of Non-Malarial Febrile Illnesses in Ugandan Children |
Philip J. Rosenthal, MD |
Malaria, Pediatrics |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
A Multi-Centric Evaluation of a Device for Automated Malaria Microscopy (EasyScan Go) |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Berkeley's Minority Health/Global Health Training Program |
Philip J. Rosenthal, MD |
Neglected Tropical Diseases (NTDs), HIV/AIDS, Malaria, Residencies, Fellowships, and Postdoctoral Training |
|
|
Translational Studies of Antimalarial Drug Resistance |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Training in Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Clinical and Molecular Studies of Drug Resistant Malaria [I] |
Philip J. Rosenthal, MD |
Malaria |
|
|
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [II] |
Philip J. Rosenthal, MD |
Infectious Disease, Neglected Tropical Diseases (NTDs), Malaria |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Therapies |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Pharmacodynamics of Antimalarial Chemoprevention |
Philip J. Rosenthal, MD |
Malaria, Pharmacology and Drug Treatment |
|
|
Training In Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building |
|
|
Training In Malaria Research in Uganda |
Philip J. Rosenthal, MD |
Malaria, Training and Capacity Building |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies |
Philip J. Rosenthal, MD |
Malaria |
|
|
Fighting emerging antimalarial drug resistance |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Chemicals with Potential Activity against Malaria Parasites |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Evaluation of Falcipain as an Antimalarial Drug Target |
Philip J. Rosenthal, MD |
Malaria |
|
|
Development of Antimalarial Drug Leads Through Inhibition of Food Vacuole Falcipains |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Falcipain Cysteine Proteases of Malaria Parasites |
Philip J. Rosenthal, MD |
Malaria |
|
|
A Prospective Cohort Study of the association between HIV and Malaria Incidence and Response to Antimalarial Therapy in African Children |
Philip J. Rosenthal, MD |
HIV/AIDS, Malaria, Pediatrics |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria |
|
|
Comparison of Home-Based Management of Fever/Malaria to Enhanced Health Facility-Based Care in Tororo, Uganda |
Philip J. Rosenthal, MD |
Malaria |
|
|
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach |
George Rutherford, MD |
HIV/AIDS, Tuberculosis, Malaria |
|
|
Global Fund Prospective Country Evaluations |
George Rutherford, MD |
Infectious Disease, Tuberculosis, Malaria, Women's Health, Pediatrics |
|
|
Global Fund SR2020 |
Starley Shade, PhD, MPH |
Infectious Disease, Tuberculosis, Malaria |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Time to negativity of Plasmodium falciparum histidine-rich protein 2 rapid diagnostic tests (RDT) in Zambezi region Namibia |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
Preparation of Background Papers to Inform the Gates Foundation Malaria Strategy |
Roland Gosling, PhD, MS, MD |
Malaria |
|
|
Operational Infectious Disease Research - Research Support Across Southeast Asia |
Roland Gosling, PhD, MS, MD |
Malaria, Policy and Standards of Care |
|
|
Preparing Vietnam for Malaria Elimination |
Roland Gosling, PhD, MS, MD |
Malaria, Policy and Standards of Care, Epidemiology and Surveillance |
|
|
UNAM Student Research Projects |
Roland Gosling, PhD, MS, MD |
Malaria, Epidemiology and Surveillance |
|
|
Donation of Primaquine for the UCSF-Sponsored Phase 2A Dose Escalation Study of the Efficacy, Safety and Pharmacokinetics of Low Single-Dose Primaquine for Gametocytocidal Activity against P. Falciparum in Sub-Saharan Africa |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
Rwanda Malaria Elimination Feasibility Assessment |
Roland Gosling, PhD, MS, MD |
Malaria |
|
|
Producing advocacy and summary materials of; malaria control, surveillance strategies, & efficacy of drug based transmission interventions |
Roland Gosling, PhD, MS, MD |
Malaria, Systematic Reviews and Guideline Development |
|
|
Eliminating Plasmodium falciparum with artemisinin combination treatments (ACTs) in sub-Saharan Africa |
Roland Gosling, PhD, MS, MD |
Malaria |
|
|
Swaziland Malaria Indicator Survey 2010 |
Michelle Hsiang, MD |
Malaria, Epidemiology and Surveillance, Health Systems Strengthening |
|
|
Swaziland Serology Technical Assistance |
Michelle Hsiang, MD |
Malaria, Drug and Diagnostics Development |
|
|
Swaziland PCR Laboratory Technician Training Contract |
Michelle Hsiang, MD |
Malaria |
|
|
Swaziland PCR Laboratory Technician Training Contract |
Michelle Hsiang, MD |
Malaria, Training International Scholars and Clinicians |
|
|
Swaziland Serology Technical Assistance |
Michelle Hsiang, MD |
Malaria |
|
|
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland |
Michelle Hsiang, MD |
Malaria |
|
|
Improving the health of children through clinical care and the study of malaria |
Michelle Hsiang, MD |
Malaria |
|
|
Malaria Elimination Surveillance in Swaziland: Investigation of Strategies to Improve Sensitivity and Efficiency for Detection of Secondary Cases |
Michelle Hsiang, MD |
Malaria |
|
|
Molecular, Spatial, and Temporal Tracking of Parasites: A Potential Strategy for Malaria Elimination |
Michelle Hsiang, MD |
Malaria |
|
|
Assessment of Affordable Medicines Facility for Malaria Treatment |
|
Malaria, Health Economics and Effectiveness |
|
|
Commission on Investing in Health (CIH) Phase 3: Leveraging Global Health 2035 to Shape the SDGs and the Health Investments of Donor, Low-Income and Middle-Income Countries |
|
Tuberculosis, Malaria, Women's Health, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland (co-investigator) |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Epidemiology and Surveillance |
|
|
Nursing education in malarial settings |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Drug and Diagnostics Development, Implementation and Behavioral Science, Engagement in Care, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
Non- P falciparum and mixed species malarial infection in Zanzibar |
Kimberly Baltzell, RN, PhD, MS |
Malaria, Drug and Diagnostics Development |
|
|
Monitoring and Evaluation of a Malaria Control Program in Vanuatu |
|
Malaria, Epidemiology and Surveillance |
|
|
Global Health Initiatives |
|
Malaria, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening |
|
|
Cultural and Behavioral Factors Related to Malaria Transmission and Control among Hmong and Other Minority Ethnic Groups in Mainland Southeast Asia |
|
Malaria |
|
|
UCSF-GIVI CFAR East Africa Regional Director |
|
HIV/AIDS, Tuberculosis, Malaria, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Drug Resistant Malaria Clinical and Laboratory Studies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Pharmacovigilance and Antimalarial Treatment in Uganda: A Pilot Survelliance System |
|
Malaria, Epidemiology and Surveillance |
|
|
Targeting Malaria via Inhibition of Plasmodium Falciparum Enoyl-ACP |
|
Malaria |
|
|
Examination of genome instability in Plasmodium Falciparum using functional genomics |
|
Malaria, Genetics |
|
|
Impact of Placental Malaria on Neonatal Tolerance and Immunity to Malaria |
Mary Prahl, MD |
Malaria, Newborn and Infant Health |
|
|
The Immunologic Impact of In Utero Malaria Exposure and Prenatal Chemoprevention |
Mary Prahl, MD |
Malaria, Newborn and Infant Health |
|
|
PSI Myanmar-2016 Malaria Writing Workshop |
May Sudhinaraset, PhD |
Malaria, Training International Scholars and Clinicians |
|
|
Restratification of Epidemiology & Development of Interventions For More Effective Control & Elimination of Malaria in Vietnam |
|
Malaria, Epidemiology and Surveillance, Health Systems Strengthening |
|
|
Evidence for Malaria Elimination and Control in Zambia |
Adam Bennett, PhD, MA |
Malaria, Epidemiology and Surveillance |
|
|
Building evidence to support safe radical cure for P. vivax in Lao PDR: operational research in collaboration with UCSF |
Adam Bennett, PhD, MA |
Malaria, Pharmacology and Drug Treatment |
|
|
Malaria Elimination Realised through Community focused Interventions (MERCI) |
Adam Bennett, PhD, MA |
Malaria, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
Impact analysis of a community-randomized controlled trial in Southern Province, Zambia |
Adam Bennett, PhD, MA |
Malaria, Implementation and Behavioral Science |
|
|
Surveillance, monitoring, and evaluation for malaria |
Adam Bennett, PhD, MA |
Malaria, Epidemiology and Surveillance |
|
|
Assessing community-based reactive case detection and treatment of P falciparum and P vivax malaria in high risk populations in Thailand and Laos |
Adam Bennett, PhD, MA |
Malaria |
|
|
Preparing Lao PDR for malaria elimination |
Adam Bennett, PhD, MA |
Malaria |
|
|
A Novel Myeloid Subset Mediating Tolerance to Malaria |
|
Malaria, Immunology |
|
|
Evaluation of malaria surveillance data processing in Swaziland: Preparation for introducing a cloud-based Disease Surveillance and Risk Mapping (DiSARM) platform |
Felix Holl, MS |
Malaria, Epidemiology and Surveillance |
|
|
Barriers to point-of-care G6PD testing for P.vivax malaria in Malaysia: a qualitative study |
Jessica Jaswal, MS |
Malaria, Drug and Diagnostics Development, Access or Barriers to Care |
|
|
Identifying factors for asymptomatic malaria in the Zambezi region of Namibia: a cross-sectional study |
Patrick McCreesh, MS |
Malaria |
|
|
Care-Seeking Behavior for Fever in Zambezi Region, Namibia: A Cross-Sectional Survey |
Caitlin Moe, MS |
Malaria, Access or Barriers to Care |
|
|
Sustaining malaria elimination: the cost of program interventions for malaria elimination and the prevention of reintroduction in the Philippines |
Stephanie Sario, MS |
Malaria |
|
|
Analysis of the rapid policy change toward empirical treatment of fever with artemisinin-based combination therapy in Ebola-burdened areas of Liberia |
Matt Susko, MS |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Policy and Standards of Care |
|
|
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) |
Michael Harrison, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians |
|
|
Identifying and targeting populations at risk of malaria |
Hugh Sturrock, PhD |
Malaria, Epidemiology and Surveillance |
|
|
Estimating the Effect of Indoor Residual Spraying on Maternal Morality, Low-Birthweight and Perinatal Mortality Among HIV-Infected Pregnant Women Living in the HAART Era |
Hugh Sturrock, PhD |
HIV/AIDS, Malaria, Women's Health, Newborn and Infant Health |
|
|
Utility of Rapid Diagnostic Tests for Malaria |
|
Malaria, Drug and Diagnostics Development, Pediatrics |
|
|
Malaria diagnostic strategies and management of febrile patients in malaria-endemic areas |
|
Malaria |
|
|
Malaria and private sector impacts in health systems |
Arian Hatefi, MD, MS |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Development of a transition assessment tool for malaria eliminating countries |
|
Malaria |
|
|
Results for Malaria Control in Asia and the Pacific (RECAP) |
|
Malaria |
|
|
Projecting the Changes in Malaria Distribution in sub-Saharan Africa under Climate Change Scenarios: a Systematic Review |
Knox Kelly, MS |
Malaria |
|
|
Understanding the community acceptability of reactive targeted mass drug administration and indoor residual spraying for malaria elimination: a qualitative study in Zambezi Region, Namibia |
Aly Maglior, MS |
Malaria |
|
|
Investigating the Impact of In Utero HIV or Malaria Exposure on CD4+ T Cell Development |
|
HIV/AIDS, Malaria, Newborn and Infant Health |
|
|
Antimalarial drugs in Ugandan populations |
Melissa Conrad, PhD |
HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics |
|
|
The impact of antimalarial resistance on malaria transmission in Uganda |
Melissa Conrad, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Technical Assistance to develop a malaria specific annex for the Sustainability Transition, and Co-financing Guidance Note through STE-SI |
Sara Fewer |
Malaria, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Conducting a transition readiness assessment for malaria (TRA-M), develop a transition plan, and revise the National Malaria Program Strategic Plan |
Sara Fewer |
Malaria, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Enabling Better Planned Transitions of Malaria Programming from Global Fund Financing to Domestic Financing |
Sara Fewer |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care |
|
|
Clinical care and medical education |
David Sears, MD |
Infectious Disease, HIV/AIDS, Malaria |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos Burroughs Wellcome Fund |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Mobile Technology for Malaria Elimination: |
Emma Zorensky, MS |
Malaria, Epidemiology and Surveillance |
|
|
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains |
Sumayya Mohammed, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics |
|
|
Factors Associated with G6PD Deficiency Testing Adherence Among P. vivax RDT-positive Individuals Living in Southern Lao PDR |
Resego Bokete, MS |
Malaria, Drug and Diagnostics Development |
|
|
Decision Support Platform for Malaria Interventions: Evaluate Productivity Improvements to Indoor Residual Spraying Activity by Spatial Optimizations to Disease Surveillance and Risk Monitoring (DiSARM) Platform |
Vikram Sridharan, MS |
Malaria, Epidemiology and Surveillance |
|
|
Forest-Goers at Risk: A Case-Control Study of Malaria in Southeast Asia |
Omar Sajjad, MS |
Malaria |
|
|
The impact of vector control interventions on adverse birth outcomes. |
Michelle Roh, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Women's Health, Newborn and Infant Health |
|
|
Bite Interruption Toward Elimination (BITE) |
Allison J. Tatarsky, MPH |
Malaria, Epidemiology and Surveillance |
|
|
Innovative intervention for reducing outdoor malaria transmission |
Allison J. Tatarsky, MPH |
Malaria, Epidemiology and Surveillance |
|
|
DFAT Vector Control Technical Landscape Analysis in the Indo-Pacific |
Allison J. Tatarsky, MPH |
Malaria |
|
|
SmartNet -electronic bednet adherence tool |
Paul Krezanoski, MD |
Malaria |
|
|
Malaria prevention during pregnancy and for young children in Uganda |
Erika K. Wallender, MD |
Malaria, Training and Capacity Building, Training International Scholars and Clinicians, Distance learning and mentoring |
|
|
PK/PD modeling to optimize prevention in African children |
Erika K. Wallender, MD |
Malaria, Pharmacology and Drug Treatment |
|
|
UnMASC: Uganda Malaria Actionable Surveillance in the time of Coronavirus |
Melawit Tekeste, MS |
Malaria, Epidemiology and Surveillance |
|
|
Technical Assistance in Program Management |
Amanda M. Chung, MPH |
Malaria |
|
|
Landscape analysis to generate programmatic and economic evidence to inform the initiative for malaria elimination in Melanesia and Timor-Leste |
Kaitlyn Fox, MBA |
Malaria, Health Economics and Effectiveness, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Regional Investment Case in the Guyana Shield |
Kaitlyn Fox, MBA |
Malaria |
|
|